英矽智能（03696.HK）今日盘中股价大幅拉升，涨幅达5.28%，引起市场广泛关注。
消息面上，公司宣布与全球医药巨头礼来（Eli Lilly）达成一项对外授权及全球研发合作协议。根据协议，礼来将支付1.15亿美元的首付款，后续开发、监管及商业化里程碑付款与销售分成合计，该交易总价值最高可达27.5亿美元。这笔巨额合作被视为AI制药领域的里程碑事件，标志着顶级药企对英矽智能AI技术平台及其药物研发能力的深度认可与战略背书，极大提振了市场对公司未来商业价值和增长潜力的信心。
此外，公司同期发布的2025年业绩显示，全年实现收入5624万美元，现金储备达3.93亿美元，展现了在行业融资环境趋紧背景下的财务韧性与持续造血能力。多重利好因素叠加，共同推动了股价的强势表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments